Does an Association among Sarcopenia and Metabolic Risk Factors Exist in People Older Than 65 Years? A Systematic Review and Meta-Analysis of Observational Studies
Authors:
- María del Carmen Carcelén-FraileMCMaría del Carmen Carcelén-Fraile
- Agustín Aibar-AlmazánAgustín Aibar-Almazán
- Diego Fernando Afanador-RestrepoDiego Fernando Afanador-Restrepo
- Yulieth Rivas-CampoYRYulieth Rivas-Campo
- Carlos Rodríguez-LópezCRCarlos Rodríguez-López
- María del Mar Carcelén-FraileMCMaría del Mar Carcelén-Fraile
- Yolanda Castellote-CaballeroYCYolanda Castellote-Caballero
- Fidel Hita-ContrerasFidel Hita-Contreras
Open Access
Abstract
Sarcopenia is defined as the generalized and progressive loss of skeletal muscle strength and mass that may be affected by metabolic factors, although this relationship has been poorly studied. The aim of this review and meta-analysis was to analyze the relationship among the different metabolic risk factors and sarcopenia in people older than 65 years. Following the PRISMA 2020 guide, we searched for articles that studied the relationship among sarcopenia and metabolic risk factors in adults over 65 years of age, published between 2012 and 2022 in four databases: PubMed, Web of Science, Cochrane Plus, and CINAHL. A total of 370 articles were identified in the initial search, of which 13 articles were selected for inclusion in this review. It was observed that metabolic risk factors such as Body Mass Index, systolic and diastolic blood pressure, glucose, cholesterol, or triglycerides had a significant association with sarcopenia. There is evidence of the association of different metabolic risk factors with sarcopenia in adults over 65 years of age, so it is necessary to carry out studies that investigate different strategies that reduce the appearance of sarcopenia, and with it, the incidence of metabolic diseases.Keywords
This publication has 60 references indexed in Scilit:
- Sarcopenia Is Independently Associated with Cardiovascular Disease in Older Korean Adults: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2009PLOS ONE, 2013
- Clinical and Physiopathological Mechanism of SarcopeniaThe Korean Journal of Medicine, 2012
- Metabolic syndrome: definitions and controversiesBMC Medicine, 2011
- An overview of sarcopenia: facts and numbers on prevalence and clinical impactJournal of Cachexia, Sarcopenia and Muscle, 2010
- Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trialsTherapeutic Advances in Chronic Disease, 2010
- Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)Diabetes Care, 2010
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2010
- Increased visceral fat and decreased energy expenditure during the menopausal transitionInternational Journal of Obesity, 2008
- A Geospatial Analysis of Emergency Transport and Inter-Hospital Transfer in ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2008